Streptococcus Pneumoniae Pneumococcus Infections Pipeline Review H2

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (Symbol:002219) SWOT Analysis, Strategy, Revenues and Profits

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (Symbol:002219) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Gansu Duyiwei Biological Pharmaceutical Co., Ltd. SWOT Analysis report ...

Industries: Drug and Medication | Countries: China

TTY Biopharm Company Limited (Symbol:4105) SWOT Analysis, Strategy, Revenues and Profits

TTY Biopharm Company Limited (Symbol:4105) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. TTY Biopharm Company Limited SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: China

JiLin AoDong Medicine Industry Group Co., Ltd. (Symbol:000623) SWOT Analysis, Strategy, Revenues and Profits

JiLin AoDong Medicine Industry Group Co., Ltd. (Symbol:000623) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. JiLin AoDong Medicine Industry Group Co., Ltd. SWOT Analysis report ...

Industries: Drug and Medication | Countries: China

China Resources Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic SWOT Analysis Review

China Resources Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources), formerly Beijing Double-Crane Pharmaceutical Co., Ltd., is a pharmaceutical company. The company carries out the manufacturing, processing and distributing pharmaceuticals. Its products are classified into three categories, ...

Industries: Drug and Medication | Countries: China

Huapont-Nutrichem Co., Ltd (002004) - Financial and Strategic SWOT Analysis Review

Huapont-Nutrichem Co., Ltd (002004) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Huapont-Nutrichem Co., Ltd (Huapont-Nutrichem) formerly Chongqing Huapont Pharm. Co., Ltd. is a pharmaceutical company, based in China. The company manufactures and markets active pharmaceutical ingredients (APIs). Its active pharmaceutical ingredients include alitretinoin, bexarotene, isotretinoin, ...

Industries: Drug and Medication | Countries: China

Chang An Info Industry (Group) Co.,Ltd - Strategic SWOT Analysis Review

Chang An Info Industry (Group) Co.,Ltd - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary Chang'an Information Industry (Group) Co., Ltd. (Chang'an) is a pharmaceuticals service provider. The company offers medical services, medical equipment, pharmaceutical investments, pharmaceutical manufacturing, computer applications, and real estate development, commercial distribution, management, ...

Industries: Drug and Medication | Countries: China

Beijing Zizhu Pharmaceutical Co., Ltd SWOT Analysis, Strategy, Revenues and Profits

Beijing Zizhu Pharmaceutical Co., Ltd SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: China

Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review

Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Yabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company. The company manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs, and health care products. Its products include sennae leaf, senna pods, clove, rhubarb, compound ...

Industries: Drug and Medication | Countries: China

Zhejiang Jingxin Pharmaceutical Co., Ltd (Symbol:002020) SWOT Analysis, Strategy, Revenues and Profits

Zhejiang Jingxin Pharmaceutical Co., Ltd (Symbol:002020) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Zhejiang Jingxin Pharmaceutical Co., Ltd SWOT Analysis report provides ...

Industries: Drug and Medication | Countries: China

China Medicine Corporation (Symbol:CHME) SWOT Analysis, Strategy, Revenues and Profits

China Medicine Corporation (Symbol:CHME) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. China Medicine Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.